Yu Y. Ng
Singapore, 117599, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Exploring Lymph Node Stroma Ageing: Immune Implications and Future Directions.
Journal: Aging cell
Published: September 18, 2024
T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivo.
Journal: Journal of cancer research and clinical oncology
Published: January 13, 2023
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis.
Journal: Cancer immunology, immunotherapy : CII
Published: April 12, 2022
piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells.
Journal: Molecular therapy. Methods & clinical development
Published: July 16, 2021
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model.
Journal: Cancer gene therapy
Published: November 27, 2020
Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells.
Journal: Molecular therapy. Methods & clinical development
Published: August 13, 2020
Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts.
Journal: Molecular therapy oncolytics
Published: April 05, 2020
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts.
Journal: Molecular therapy oncolytics
Published: December 06, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026